| Authors: |
Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.; Department of Surgery, Duke University, Durham, NC, USA. kevin.saunders@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu., Lee E; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Li D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Chen H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Gobeil S; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Barr M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Alam SM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Sutherland LL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Cai F; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Sanzone AM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Berry M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Manne K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Bock KW; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Minai M; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Nagata BM; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Kapingidza AB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Azoitei M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Tse LV; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Scobey TD; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Rountree RW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., DeMarco CT; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Denny TN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Woods CW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC, USA., Petzold EW; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC, USA., Tang J; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD, USA., Oguin TH 3rd; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Sempowski GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Gagne M; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Douek DC; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Tomai MA; Corporate Research Materials Lab, 3M Company, St Paul, MN, USA., Fox CB; Infectious Disease Research Institute, Seattle, WA, USA., Seder R; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Wiehe K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Weissman D; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pardi N; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Golding H; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD, USA., Acharya P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University, Durham, NC, USA., Andersen H; BIOQUAL, Rockville, MD, USA., Lewis MG; BIOQUAL, Rockville, MD, USA., Moore IN; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University, Durham, NC, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. barton.haynes@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, NC, USA. barton.haynes@duke.edu.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. barton.haynes@duke.edu. |
